QbD Group
    Serialization in the EU can become a competitive advantage if you dare to innovate

    Serialization in the EU can become a competitive advantage if you dare to innovate

    In an attempt to reduce counterfeiting in the pharmaceutical industry, the European Union has issued the Falsified Medicine Directive (2011/62/EU).

    January 16, 20190 min read

    QbD Group

    Ready to accelerate your life sciences project? Talk to our experts.

    Get expert guidance →
    Share this article

    Subscribe to the latest updates in life science

    Expert perspectives delivered to your inbox — pick your interests.

    No spam, ever. Unsubscribe anytime.